ZMYM2 and parasitic infectious disease: Considering that it is necessary to improve new approaches to investigate the usefulness of more effective and non-toxic agents for treatment of patients with toxoplasmosis, in addition to the fact that ScLL and ArtinM have been previously used only in vaccination protocols for parasitic infections, the major aim of the present study was to evaluate whether these lectins could be also applicable as therapeutic agents to avoid the tissue damages occurring in consequence of T. gondii infection.